Search

HYPOPHARYNGEAL CANCER BEFORE AND DURING THE ORGAN PRESERVATION EPOCH: A THIRTY-YEAR EXPERIENCE

Pharynx / Larynx Cancer

Adam C Gaunt, Dr¹, Stephanie L Koonce, Dr², Rachel J Lawrence, Dr¹, George Garas, Dr³, Patrick J Bradley, Mr¹, David G Grant, Dr¹

¹Queens Medical Centre, Nottingham UK, ²Cleveland Clinic, Florida USA, ³Imperial College and St Mary's Hospital, London UK

DIFFERENT CLINICOPATHOLOGICAL PROFILES OF HPV-POSITIVE VERSUS HPV-NEGATIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS, WITH THE COMPLICATING FACTOR OF SMOKING: THE USC EXPERIENCE

Pharynx / Larynx Cancer

Changxing Liu, MD, PhD, Uttam K Sinha, MD, Niels Kokot, MD

USC Tina and Rick Caruso Department of Otolaryngology-Head and Neck Surgery, Keck Medicine of USC, University of Southern California

IMPACT OF SMOKING HISTORY ON LOCOREGIONAL RECURRENCE-FREE, DISTANT METASTASIS-FREE SURVIVAL AND OVERALL SURVIVAL IN HUMAN PAPILLOMAVIRUS (HPV)-ASSOCIATED OROPHARYNGEAL CANCER (OPC) TREATED WITH DEFINITIVE (CHEMO)RADIOTHERAPY

Pharynx / Larynx Cancer

Howard Liu¹, Anne Bernard², Elizabeth Brown¹, Laura Tam¹, Matthew Foote¹, Rob Milne², Margaret McGrath¹, Reza Rahbari¹, Bena Cartmill¹, Ben Panizza¹, Sandro Porceddu¹

¹Princess Alexandra Hospital, ²University of Queensland

QUALITY OF LIFE AFTER SUPRACRICOID PARTIAL LARYNGECTOMY

Pharynx / Larynx Cancer

Marianne Y Nakai, MD, Marcelo B Menezes, PhD, Julia V Boas, Lucas Porto M Dias, Lucas R Tenorio, MD, Leandro Augusto B Silva, MD, Antonio J Goncalves, PhD

Irmandade da Santa Casa de Misericórdia de São Paulo

HPV STATUS IS NOT ASSOCIATED WITH BETTER SURVIVAL RATES IN LOW-PREVALENCE HPV INFECTION GEOGRAFIC REGIONS

Pharynx / Larynx Cancer

Rafael De Cicco, MD¹, Rosilene M Menezes, MD, PhD², Ulisses R Nicolau, MD, PhD¹, Clovis A Pinto, Md, PhD¹, Luiza L Villa, PhD³, Luiz P Kowalski, MD, PhD¹

¹AC Camargo Cancer Center, ²Hospital do Servidor Publico Municipal, ³Instituto do Cancer do Estado de São Paulo

PREOPERATIVE PREDICTORS OF DIFFICULT HYPOPHARYNGEAL EXPOSURE DURING TRANSORAL SURGERY

Pharynx / Larynx Cancer

Kazunori Fujiwara, MD, PhD, Takahiro Fukuhara, MD, PhD, Satoshi Koyama, MD, PhD, Ryohei Donishi, MD, Hiromi Takeuchi, MD, PhD

Tottori University

FIRST LINE SURGICAL TREATMENT OF OROPHARYNGEAL CARCINOMA WITH TRANS-ORAL ROBOTIC SURGERY (TORS): REVIEW OF A SINGLE INSTITUTIONS OUTCOMES

Pharynx / Larynx Cancer

Julia A Crawford, MD, Brett Leavers, Dr, Richard M Gallagher

St Vincent's Hospital Sydney

INITIALLY-POSITIVE MARGINS PREDICT WORSE SURVIVAL IN PRIMARY, BUT NOT SALVAGE, TOTAL LARYNGECTOMY

Pharynx / Larynx Cancer

Patrick Tassone, MD, Corey Savard, Michael Topf, MD, William Keane, MD, Adam Luginbuhl, MD, Joseph Curry, MD, David Cognetti, MD

Thomas Jefferson University

THE EXTENT OF NECK DISSECTION AMONG PATIENTS WHO RECEIVE ADJUVANT RADIOTHERAPY FOR HEAD AND NECK SQUAMOUS CELL CARCINOMA AND ITS EFFECT ON DISEASE- SPECIFIC AND OVERALL SURVIVAL.

Pharynx / Larynx Cancer

Usama Aboelkheir, MD, Austin Iovoli, BS, Alexis Platek, BS, Mary Platek, PhD, Anurag Singh, MD, Vishal Gupta, MD, David Cohan, MD, Wesley Hicks, MD, Hassan Arshad, MD

Roswell Park Cancer Institute

PREDICTORS OF SWALLOW FUNCTION AFTER TRANSORAL SURGERY FOR LOCALLY ADVANCED OROPHARYNGEAL CANCER

Pharynx / Larynx Cancer

Jennifer Gross, MD¹, Melanie Townsend, MD¹, Joseph Zenga, MD², Ryan Jackson, MD¹, Bruce Haughey, MD, FACS³, Jason Rich, MD¹

¹Washington University Department of Otolaryngology, ²Massachusetts Eye and Ear Infirmary, ³Florida ENT Surgical Specialists